Actively Recruiting
Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.
Led by The Third Affiliated Hospital of Beijing University of Chinese Medicine · Updated on 2025-12-19
76
Participants Needed
1
Research Sites
84 weeks
Total Duration
On this page
Sponsors
T
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Lead Sponsor
M
Mahidol University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to evaluate the efficacy of acupuncture as a treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6-12 years. Using a mixed-methods approach, the research will triangulate data from acupoint data mining, treatment outcomes assessment, and patient perspectives to provide a comprehensive analysis of acupuncture's potential therapeutic benefits for ADHD. This prospective cohort study will recruit children diagnosed with ADHD, assigning them to receive either acupuncture combined with traditional Chinese herbal treatment or herbal treatment alone. Quantitative assessments using the the SNAP-IV, Conners 3-P, BRIEF-2, PedsQL™ 4.0 Generic Core Scales, PSQI and CGI that will be complemented by qualitative interviews to capture nuanced patient experiences and treatment outcomes. The study will span 12 months, commencing on March 1st, 2025 with an expected completion by February 28th, 2026. By integrating quantitative assessments with qualitative insights, it aims to provide comprehensive evidence on acupuncture's role in ADHD management. Findings may inform clinical guidelines and enhance patient-centered care approaches.
CONDITIONS
Official Title
Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 6 to 12 years
- Confirmed ADHD diagnosis based on DSM-5 and Chinese Medicine Clinical Trial guidelines
- No use of other pharmacological treatments within two weeks before the study
- IQ score above 80 as measured by Raven's Progressive Matrices
- No prior participation in any clinical trials
You will not qualify if you...
- Not meeting the inclusion criteria
- Having comorbid psychiatric disorders, severe medical or psychiatric conditions (e.g., epilepsy, severe anxiety), pervasive developmental disorders, intellectual disability, or history of suicidal/self-harming behavior
- Participation in other drug clinical trials within the past three months
- Severe cardiovascular, liver, kidney, or blood diseases
- Any condition interfering with treatment assessment or safety as judged by researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pediatrics Outpatient Department of the Third Affiliated Hospital of Beijing University of Chinese Medicine
Beijing, Chaoyang District, China, 100036
Actively Recruiting
Research Team
T
Tananan Sangwanit, Ph.D.student
CONTACT
X
Xue Bai, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here